These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2859075)

  • 21. [Tuberculosis of peripheral lymph nodes (author's transl)].
    Kindler U; Stiehl G
    HNO; 1976 Oct; 24(10):336-8. PubMed ID: 993077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Six-month combination chemotherapy for cervical tuberculous lymphadenitis.
    Cheung WL; Siu KF; Ng A
    J R Coll Surg Edinb; 1990 Oct; 35(5):293-5. PubMed ID: 2283606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short course chemotherapy (9 months) for lymphnode tuberculosis.
    Behera D; Jindal SK
    Indian J Chest Dis Allied Sci; 1990; 32(1):73-4. PubMed ID: 2269501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Six months' chemotherapy for lymph node tuberculosis.
    McCarthy OR; Rudd RM
    Respir Med; 1989 Sep; 83(5):425-7. PubMed ID: 2616826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of surgery and chemotherapy for peripheral lymph node tuberculosis.
    Subrahmanyam M
    Br J Surg; 1993 Dec; 80(12):1547-8. PubMed ID: 8298921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
    Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of pulmonary tuberculosis in patients notified in England and Wales in 1978-9: chemotherapy and hospital admission. Medical Research Council Tuberculosis and Chest Diseases Unit.
    Thorax; 1985 Feb; 40(2):113-20. PubMed ID: 3975862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 29. A retrospective comparison of two drug regimens RHE2/RH10 and RHZ2/RH10 in the treatment of tuberculous mediastinal lymphadenopathy.
    Ormerod LP
    Br J Dis Chest; 1988 Jul; 82(3):274-81. PubMed ID: 3248208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment.
    Zierski M; Bek E; Long MW; Snider DE
    Am Rev Respir Dis; 1980 Dec; 122(6):879-89. PubMed ID: 7006476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modern management of cervical scrofula.
    Deitel M; Bendago M; Krajden S; Ronald AC; Borowy ZJ
    Head Neck; 1989; 11(1):60-6. PubMed ID: 2921112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis in East Africans presenting with intra-thoracic lymphadenopathy.
    Kabuubi JB
    Tubercle; 1978 Dec; 59(4):281-6. PubMed ID: 726086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
    Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
    Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quantitative evaluation of the dynamics of tubercular mediastinal adenopathy treated with rifampicin and ethambutol].
    Tonceanu S; Bazacliu E; Carp G; Varadi P; Ritter S; Simon F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(3):143-50. PubMed ID: 201006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco.
    Slutkin G; Schecter GF; Hopewell PC
    Am Rev Respir Dis; 1988 Dec; 138(6):1622-4. PubMed ID: 3144221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.